BiobDx Raises $8.5 Million

BioBehavioral Diagnostics Co., a Cambridge, Mass.-based developer of a diagnostic system for measuring the core components of Attention Deficit Hyperactivity Disorder (ADHD), has raised $8.5 million in Series A funding. Sevin Rosen Funds and Tullis-Dickerson co-led the deal. www.biobdx.com